BIOCHEMICAL PHARMACOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2207937, encodeId=9652220e93751, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：1.3 submitted，1.7 with editor，1.11 under review，2.8 时间变动状态不变 2.12,评审结束 2.22 DIP 2.24 reverse（1个月） 3.22 resubmitted 3.26 with editor 4.1 under review 4.3 评审结束 4.6 二返（半月），4.12 resubmitted, 4.19催稿，4.21接收，4.25 online。投稿共耗时4个月，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44f99168202, createdName=ms1000000537292872, createdTime=Sun Jun 02 17:13:38 CST 2024, time=2024-06-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病 经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2208736, encodeId=626e2208e36fc, content=5月20号投稿，23号with editor,到现在还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Fri Jun 07 00:51:29 CST 2024, time=2024-06-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2207788, encodeId=aef3220e7886f, content=4月中旬送外审 5月28显示外审完成 5月30显示DIP 6月1 仍旧是DIP, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210531/5f7cf98bc3ff42f9bdb3c8abf4b519fe/43510175e95b4dddbccc3b11e600cae0.jpg, createdBy=3c742286789, createdName=科研小白i, createdTime=Sat Jun 01 16:36:24 CST 2024, time=2024-06-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183371, encodeId=368621833e1d5, content=偏重的研究方向：肿瘤 经验分享：审稿人意见返回编辑那里有三周了，状态依然是Decision in Process，编辑一直不做决定，有没有人遇到过呢？可以发邮件催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=023d2396907, createdName=12346694m83(暂无昵称), createdTime=Tue Jan 23 09:38:03 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181993, encodeId=a44d21819936e, content=投稿后第四天变成了DIP，目前一周多了，发邮件给编辑也没反应，要拒也给我个准信呀。科研人时间上的无奈呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Tue Jan 16 15:58:49 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2203602, encodeId=b30c2203602ca, content=有没有已经有三个审稿人还在邀请评审专家的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Thu May 09 09:28:05 CST 2024, time=2024-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198105, encodeId=f3d8219810549, content=这个期刊不是说很快吗，投了10天，5天才到编辑那。现在在编辑那又呆了5天。着急毕业呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Fri Apr 12 09:34:50 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2200181, encodeId=320a2200181c2, content=到编辑那里第一台就Decision in Process，已经凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Wed Apr 24 19:40:05 CST 2024, time=2024-04-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2183494, encodeId=13e621834949b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：黏附分子;胃癌 经验分享：已经外审12周了，窒息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Tue Jan 23 20:06:15 CST 2024, time=2024-01-23, status=1, ipAttribution=上海)]

2024-06-02 ms1000000537292872 来自河北省

审稿速度:1.0 | 投稿命中率:50.0
经验分享：1.3 submitted，1.7 with editor，1.11 under review，2.8 时间变动状态不变 2.12,评审结束 2.22 DIP 2.24 reverse（1个月） 3.22 resubmitted 3.26 with editor 4.1 under review 4.3 评审结束 4.6 二返（半月），4.12 resubmitted, 4.19催稿，4.21接收，4.25 online。投稿共耗时4个月，

13 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207937, encodeId=9652220e93751, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：1.3 submitted，1.7 with editor，1.11 under review，2.8 时间变动状态不变 2.12,评审结束 2.22 DIP 2.24 reverse（1个月） 3.22 resubmitted 3.26 with editor 4.1 under review 4.3 评审结束 4.6 二返（半月），4.12 resubmitted, 4.19催稿，4.21接收，4.25 online。投稿共耗时4个月，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44f99168202, createdName=ms1000000537292872, createdTime=Sun Jun 02 17:13:38 CST 2024, time=2024-06-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病 经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2208736, encodeId=626e2208e36fc, content=5月20号投稿，23号with editor,到现在还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Fri Jun 07 00:51:29 CST 2024, time=2024-06-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2207788, encodeId=aef3220e7886f, content=4月中旬送外审 5月28显示外审完成 5月30显示DIP 6月1 仍旧是DIP, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210531/5f7cf98bc3ff42f9bdb3c8abf4b519fe/43510175e95b4dddbccc3b11e600cae0.jpg, createdBy=3c742286789, createdName=科研小白i, createdTime=Sat Jun 01 16:36:24 CST 2024, time=2024-06-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183371, encodeId=368621833e1d5, content=偏重的研究方向：肿瘤 经验分享：审稿人意见返回编辑那里有三周了，状态依然是Decision in Process，编辑一直不做决定，有没有人遇到过呢？可以发邮件催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=023d2396907, createdName=12346694m83(暂无昵称), createdTime=Tue Jan 23 09:38:03 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181993, encodeId=a44d21819936e, content=投稿后第四天变成了DIP，目前一周多了，发邮件给编辑也没反应，要拒也给我个准信呀。科研人时间上的无奈呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Tue Jan 16 15:58:49 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2203602, encodeId=b30c2203602ca, content=有没有已经有三个审稿人还在邀请评审专家的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Thu May 09 09:28:05 CST 2024, time=2024-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198105, encodeId=f3d8219810549, content=这个期刊不是说很快吗，投了10天，5天才到编辑那。现在在编辑那又呆了5天。着急毕业呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Fri Apr 12 09:34:50 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2200181, encodeId=320a2200181c2, content=到编辑那里第一台就Decision in Process，已经凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Wed Apr 24 19:40:05 CST 2024, time=2024-04-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2183494, encodeId=13e621834949b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：黏附分子;胃癌 经验分享：已经外审12周了，窒息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Tue Jan 23 20:06:15 CST 2024, time=2024-01-23, status=1, ipAttribution=上海)]

2023-05-08 ms3000001240185836 来自四川省

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：心血管疾病
经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。

49 27

展开27条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207937, encodeId=9652220e93751, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：1.3 submitted，1.7 with editor，1.11 under review，2.8 时间变动状态不变 2.12,评审结束 2.22 DIP 2.24 reverse（1个月） 3.22 resubmitted 3.26 with editor 4.1 under review 4.3 评审结束 4.6 二返（半月），4.12 resubmitted, 4.19催稿，4.21接收，4.25 online。投稿共耗时4个月，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44f99168202, createdName=ms1000000537292872, createdTime=Sun Jun 02 17:13:38 CST 2024, time=2024-06-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病 经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2208736, encodeId=626e2208e36fc, content=5月20号投稿，23号with editor,到现在还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Fri Jun 07 00:51:29 CST 2024, time=2024-06-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2207788, encodeId=aef3220e7886f, content=4月中旬送外审 5月28显示外审完成 5月30显示DIP 6月1 仍旧是DIP, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210531/5f7cf98bc3ff42f9bdb3c8abf4b519fe/43510175e95b4dddbccc3b11e600cae0.jpg, createdBy=3c742286789, createdName=科研小白i, createdTime=Sat Jun 01 16:36:24 CST 2024, time=2024-06-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183371, encodeId=368621833e1d5, content=偏重的研究方向：肿瘤 经验分享：审稿人意见返回编辑那里有三周了，状态依然是Decision in Process，编辑一直不做决定，有没有人遇到过呢？可以发邮件催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=023d2396907, createdName=12346694m83(暂无昵称), createdTime=Tue Jan 23 09:38:03 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181993, encodeId=a44d21819936e, content=投稿后第四天变成了DIP，目前一周多了，发邮件给编辑也没反应，要拒也给我个准信呀。科研人时间上的无奈呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Tue Jan 16 15:58:49 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2203602, encodeId=b30c2203602ca, content=有没有已经有三个审稿人还在邀请评审专家的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Thu May 09 09:28:05 CST 2024, time=2024-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198105, encodeId=f3d8219810549, content=这个期刊不是说很快吗，投了10天，5天才到编辑那。现在在编辑那又呆了5天。着急毕业呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Fri Apr 12 09:34:50 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2200181, encodeId=320a2200181c2, content=到编辑那里第一台就Decision in Process，已经凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Wed Apr 24 19:40:05 CST 2024, time=2024-04-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2183494, encodeId=13e621834949b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：黏附分子;胃癌 经验分享：已经外审12周了，窒息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Tue Jan 23 20:06:15 CST 2024, time=2024-01-23, status=1, ipAttribution=上海)]

2024-06-07 147a5c7fm07(暂无昵称) 来自吉林省

5月20号投稿，23号with editor,到现在还没动静

8 0

[GetPortalCommentsPageByObjectIdResponse(id=2207937, encodeId=9652220e93751, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：1.3 submitted，1.7 with editor，1.11 under review，2.8 时间变动状态不变 2.12,评审结束 2.22 DIP 2.24 reverse（1个月） 3.22 resubmitted 3.26 with editor 4.1 under review 4.3 评审结束 4.6 二返（半月），4.12 resubmitted, 4.19催稿，4.21接收，4.25 online。投稿共耗时4个月，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44f99168202, createdName=ms1000000537292872, createdTime=Sun Jun 02 17:13:38 CST 2024, time=2024-06-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病 经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2208736, encodeId=626e2208e36fc, content=5月20号投稿，23号with editor,到现在还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Fri Jun 07 00:51:29 CST 2024, time=2024-06-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2207788, encodeId=aef3220e7886f, content=4月中旬送外审 5月28显示外审完成 5月30显示DIP 6月1 仍旧是DIP, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210531/5f7cf98bc3ff42f9bdb3c8abf4b519fe/43510175e95b4dddbccc3b11e600cae0.jpg, createdBy=3c742286789, createdName=科研小白i, createdTime=Sat Jun 01 16:36:24 CST 2024, time=2024-06-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183371, encodeId=368621833e1d5, content=偏重的研究方向：肿瘤 经验分享：审稿人意见返回编辑那里有三周了，状态依然是Decision in Process，编辑一直不做决定，有没有人遇到过呢？可以发邮件催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=023d2396907, createdName=12346694m83(暂无昵称), createdTime=Tue Jan 23 09:38:03 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181993, encodeId=a44d21819936e, content=投稿后第四天变成了DIP，目前一周多了，发邮件给编辑也没反应，要拒也给我个准信呀。科研人时间上的无奈呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Tue Jan 16 15:58:49 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2203602, encodeId=b30c2203602ca, content=有没有已经有三个审稿人还在邀请评审专家的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Thu May 09 09:28:05 CST 2024, time=2024-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198105, encodeId=f3d8219810549, content=这个期刊不是说很快吗，投了10天，5天才到编辑那。现在在编辑那又呆了5天。着急毕业呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Fri Apr 12 09:34:50 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2200181, encodeId=320a2200181c2, content=到编辑那里第一台就Decision in Process，已经凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Wed Apr 24 19:40:05 CST 2024, time=2024-04-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2183494, encodeId=13e621834949b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：黏附分子;胃癌 经验分享：已经外审12周了，窒息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Tue Jan 23 20:06:15 CST 2024, time=2024-01-23, status=1, ipAttribution=上海)]

2024-06-01 科研小白i 来自江苏省

4月中旬送外审 5月28显示外审完成 5月30显示DIP 6月1 仍旧是DIP

7 0

[GetPortalCommentsPageByObjectIdResponse(id=2207937, encodeId=9652220e93751, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：1.3 submitted，1.7 with editor，1.11 under review，2.8 时间变动状态不变 2.12,评审结束 2.22 DIP 2.24 reverse（1个月） 3.22 resubmitted 3.26 with editor 4.1 under review 4.3 评审结束 4.6 二返（半月），4.12 resubmitted, 4.19催稿，4.21接收，4.25 online。投稿共耗时4个月，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44f99168202, createdName=ms1000000537292872, createdTime=Sun Jun 02 17:13:38 CST 2024, time=2024-06-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病 经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2208736, encodeId=626e2208e36fc, content=5月20号投稿，23号with editor,到现在还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Fri Jun 07 00:51:29 CST 2024, time=2024-06-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2207788, encodeId=aef3220e7886f, content=4月中旬送外审 5月28显示外审完成 5月30显示DIP 6月1 仍旧是DIP, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210531/5f7cf98bc3ff42f9bdb3c8abf4b519fe/43510175e95b4dddbccc3b11e600cae0.jpg, createdBy=3c742286789, createdName=科研小白i, createdTime=Sat Jun 01 16:36:24 CST 2024, time=2024-06-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183371, encodeId=368621833e1d5, content=偏重的研究方向：肿瘤 经验分享：审稿人意见返回编辑那里有三周了，状态依然是Decision in Process，编辑一直不做决定，有没有人遇到过呢？可以发邮件催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=023d2396907, createdName=12346694m83(暂无昵称), createdTime=Tue Jan 23 09:38:03 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181993, encodeId=a44d21819936e, content=投稿后第四天变成了DIP，目前一周多了，发邮件给编辑也没反应，要拒也给我个准信呀。科研人时间上的无奈呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Tue Jan 16 15:58:49 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2203602, encodeId=b30c2203602ca, content=有没有已经有三个审稿人还在邀请评审专家的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Thu May 09 09:28:05 CST 2024, time=2024-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198105, encodeId=f3d8219810549, content=这个期刊不是说很快吗，投了10天，5天才到编辑那。现在在编辑那又呆了5天。着急毕业呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Fri Apr 12 09:34:50 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2200181, encodeId=320a2200181c2, content=到编辑那里第一台就Decision in Process，已经凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Wed Apr 24 19:40:05 CST 2024, time=2024-04-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2183494, encodeId=13e621834949b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：黏附分子;胃癌 经验分享：已经外审12周了，窒息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Tue Jan 23 20:06:15 CST 2024, time=2024-01-23, status=1, ipAttribution=上海)]

2024-01-23 12346694m83(暂无昵称) 来自浙江省

偏重的研究方向：肿瘤
经验分享：审稿人意见返回编辑那里有三周了，状态依然是Decision in Process，编辑一直不做决定，有没有人遇到过呢？可以发邮件催一下吗？

36 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207937, encodeId=9652220e93751, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：1.3 submitted，1.7 with editor，1.11 under review，2.8 时间变动状态不变 2.12,评审结束 2.22 DIP 2.24 reverse（1个月） 3.22 resubmitted 3.26 with editor 4.1 under review 4.3 评审结束 4.6 二返（半月），4.12 resubmitted, 4.19催稿，4.21接收，4.25 online。投稿共耗时4个月，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44f99168202, createdName=ms1000000537292872, createdTime=Sun Jun 02 17:13:38 CST 2024, time=2024-06-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病 经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2208736, encodeId=626e2208e36fc, content=5月20号投稿，23号with editor,到现在还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Fri Jun 07 00:51:29 CST 2024, time=2024-06-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2207788, encodeId=aef3220e7886f, content=4月中旬送外审 5月28显示外审完成 5月30显示DIP 6月1 仍旧是DIP, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210531/5f7cf98bc3ff42f9bdb3c8abf4b519fe/43510175e95b4dddbccc3b11e600cae0.jpg, createdBy=3c742286789, createdName=科研小白i, createdTime=Sat Jun 01 16:36:24 CST 2024, time=2024-06-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183371, encodeId=368621833e1d5, content=偏重的研究方向：肿瘤 经验分享：审稿人意见返回编辑那里有三周了，状态依然是Decision in Process，编辑一直不做决定，有没有人遇到过呢？可以发邮件催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=023d2396907, createdName=12346694m83(暂无昵称), createdTime=Tue Jan 23 09:38:03 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181993, encodeId=a44d21819936e, content=投稿后第四天变成了DIP，目前一周多了，发邮件给编辑也没反应，要拒也给我个准信呀。科研人时间上的无奈呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Tue Jan 16 15:58:49 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2203602, encodeId=b30c2203602ca, content=有没有已经有三个审稿人还在邀请评审专家的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Thu May 09 09:28:05 CST 2024, time=2024-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198105, encodeId=f3d8219810549, content=这个期刊不是说很快吗，投了10天，5天才到编辑那。现在在编辑那又呆了5天。着急毕业呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Fri Apr 12 09:34:50 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2200181, encodeId=320a2200181c2, content=到编辑那里第一台就Decision in Process，已经凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Wed Apr 24 19:40:05 CST 2024, time=2024-04-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2183494, encodeId=13e621834949b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：黏附分子;胃癌 经验分享：已经外审12周了，窒息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Tue Jan 23 20:06:15 CST 2024, time=2024-01-23, status=1, ipAttribution=上海)]

2024-01-16 ms5000001598335110 来自湖南省

投稿后第四天变成了DIP，目前一周多了，发邮件给编辑也没反应，要拒也给我个准信呀。科研人时间上的无奈呀。

22 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207937, encodeId=9652220e93751, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：1.3 submitted，1.7 with editor，1.11 under review，2.8 时间变动状态不变 2.12,评审结束 2.22 DIP 2.24 reverse（1个月） 3.22 resubmitted 3.26 with editor 4.1 under review 4.3 评审结束 4.6 二返（半月），4.12 resubmitted, 4.19催稿，4.21接收，4.25 online。投稿共耗时4个月，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44f99168202, createdName=ms1000000537292872, createdTime=Sun Jun 02 17:13:38 CST 2024, time=2024-06-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病 经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2208736, encodeId=626e2208e36fc, content=5月20号投稿，23号with editor,到现在还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Fri Jun 07 00:51:29 CST 2024, time=2024-06-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2207788, encodeId=aef3220e7886f, content=4月中旬送外审 5月28显示外审完成 5月30显示DIP 6月1 仍旧是DIP, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210531/5f7cf98bc3ff42f9bdb3c8abf4b519fe/43510175e95b4dddbccc3b11e600cae0.jpg, createdBy=3c742286789, createdName=科研小白i, createdTime=Sat Jun 01 16:36:24 CST 2024, time=2024-06-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183371, encodeId=368621833e1d5, content=偏重的研究方向：肿瘤 经验分享：审稿人意见返回编辑那里有三周了，状态依然是Decision in Process，编辑一直不做决定，有没有人遇到过呢？可以发邮件催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=023d2396907, createdName=12346694m83(暂无昵称), createdTime=Tue Jan 23 09:38:03 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181993, encodeId=a44d21819936e, content=投稿后第四天变成了DIP，目前一周多了，发邮件给编辑也没反应，要拒也给我个准信呀。科研人时间上的无奈呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Tue Jan 16 15:58:49 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2203602, encodeId=b30c2203602ca, content=有没有已经有三个审稿人还在邀请评审专家的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Thu May 09 09:28:05 CST 2024, time=2024-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198105, encodeId=f3d8219810549, content=这个期刊不是说很快吗，投了10天，5天才到编辑那。现在在编辑那又呆了5天。着急毕业呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Fri Apr 12 09:34:50 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2200181, encodeId=320a2200181c2, content=到编辑那里第一台就Decision in Process，已经凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Wed Apr 24 19:40:05 CST 2024, time=2024-04-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2183494, encodeId=13e621834949b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：黏附分子;胃癌 经验分享：已经外审12周了，窒息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Tue Jan 23 20:06:15 CST 2024, time=2024-01-23, status=1, ipAttribution=上海)]

2024-05-09 ms6000002080703872 来自江苏省

有没有已经有三个审稿人还在邀请评审专家的

11 0

[GetPortalCommentsPageByObjectIdResponse(id=2207937, encodeId=9652220e93751, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：1.3 submitted，1.7 with editor，1.11 under review，2.8 时间变动状态不变 2.12,评审结束 2.22 DIP 2.24 reverse（1个月） 3.22 resubmitted 3.26 with editor 4.1 under review 4.3 评审结束 4.6 二返（半月），4.12 resubmitted, 4.19催稿，4.21接收，4.25 online。投稿共耗时4个月，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44f99168202, createdName=ms1000000537292872, createdTime=Sun Jun 02 17:13:38 CST 2024, time=2024-06-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病 经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2208736, encodeId=626e2208e36fc, content=5月20号投稿，23号with editor,到现在还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Fri Jun 07 00:51:29 CST 2024, time=2024-06-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2207788, encodeId=aef3220e7886f, content=4月中旬送外审 5月28显示外审完成 5月30显示DIP 6月1 仍旧是DIP, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210531/5f7cf98bc3ff42f9bdb3c8abf4b519fe/43510175e95b4dddbccc3b11e600cae0.jpg, createdBy=3c742286789, createdName=科研小白i, createdTime=Sat Jun 01 16:36:24 CST 2024, time=2024-06-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183371, encodeId=368621833e1d5, content=偏重的研究方向：肿瘤 经验分享：审稿人意见返回编辑那里有三周了，状态依然是Decision in Process，编辑一直不做决定，有没有人遇到过呢？可以发邮件催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=023d2396907, createdName=12346694m83(暂无昵称), createdTime=Tue Jan 23 09:38:03 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181993, encodeId=a44d21819936e, content=投稿后第四天变成了DIP，目前一周多了，发邮件给编辑也没反应，要拒也给我个准信呀。科研人时间上的无奈呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Tue Jan 16 15:58:49 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2203602, encodeId=b30c2203602ca, content=有没有已经有三个审稿人还在邀请评审专家的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Thu May 09 09:28:05 CST 2024, time=2024-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198105, encodeId=f3d8219810549, content=这个期刊不是说很快吗，投了10天，5天才到编辑那。现在在编辑那又呆了5天。着急毕业呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Fri Apr 12 09:34:50 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2200181, encodeId=320a2200181c2, content=到编辑那里第一台就Decision in Process，已经凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Wed Apr 24 19:40:05 CST 2024, time=2024-04-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2183494, encodeId=13e621834949b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：黏附分子;胃癌 经验分享：已经外审12周了，窒息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Tue Jan 23 20:06:15 CST 2024, time=2024-01-23, status=1, ipAttribution=上海)]

2024-04-12 ms6000002080703872 来自江苏省

这个期刊不是说很快吗，投了10天，5天才到编辑那。现在在编辑那又呆了5天。着急毕业呢

20 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207937, encodeId=9652220e93751, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：1.3 submitted，1.7 with editor，1.11 under review，2.8 时间变动状态不变 2.12,评审结束 2.22 DIP 2.24 reverse（1个月） 3.22 resubmitted 3.26 with editor 4.1 under review 4.3 评审结束 4.6 二返（半月），4.12 resubmitted, 4.19催稿，4.21接收，4.25 online。投稿共耗时4个月，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44f99168202, createdName=ms1000000537292872, createdTime=Sun Jun 02 17:13:38 CST 2024, time=2024-06-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病 经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2208736, encodeId=626e2208e36fc, content=5月20号投稿，23号with editor,到现在还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Fri Jun 07 00:51:29 CST 2024, time=2024-06-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2207788, encodeId=aef3220e7886f, content=4月中旬送外审 5月28显示外审完成 5月30显示DIP 6月1 仍旧是DIP, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210531/5f7cf98bc3ff42f9bdb3c8abf4b519fe/43510175e95b4dddbccc3b11e600cae0.jpg, createdBy=3c742286789, createdName=科研小白i, createdTime=Sat Jun 01 16:36:24 CST 2024, time=2024-06-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183371, encodeId=368621833e1d5, content=偏重的研究方向：肿瘤 经验分享：审稿人意见返回编辑那里有三周了，状态依然是Decision in Process，编辑一直不做决定，有没有人遇到过呢？可以发邮件催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=023d2396907, createdName=12346694m83(暂无昵称), createdTime=Tue Jan 23 09:38:03 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181993, encodeId=a44d21819936e, content=投稿后第四天变成了DIP，目前一周多了，发邮件给编辑也没反应，要拒也给我个准信呀。科研人时间上的无奈呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Tue Jan 16 15:58:49 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2203602, encodeId=b30c2203602ca, content=有没有已经有三个审稿人还在邀请评审专家的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Thu May 09 09:28:05 CST 2024, time=2024-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198105, encodeId=f3d8219810549, content=这个期刊不是说很快吗，投了10天，5天才到编辑那。现在在编辑那又呆了5天。着急毕业呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Fri Apr 12 09:34:50 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2200181, encodeId=320a2200181c2, content=到编辑那里第一台就Decision in Process，已经凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Wed Apr 24 19:40:05 CST 2024, time=2024-04-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2183494, encodeId=13e621834949b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：黏附分子;胃癌 经验分享：已经外审12周了，窒息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Tue Jan 23 20:06:15 CST 2024, time=2024-01-23, status=1, ipAttribution=上海)]

2024-04-24 xgwan123 来自辽宁省

到编辑那里第一台就Decision in Process，已经凉凉了

11 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207937, encodeId=9652220e93751, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：1.3 submitted，1.7 with editor，1.11 under review，2.8 时间变动状态不变 2.12,评审结束 2.22 DIP 2.24 reverse（1个月） 3.22 resubmitted 3.26 with editor 4.1 under review 4.3 评审结束 4.6 二返（半月），4.12 resubmitted, 4.19催稿，4.21接收，4.25 online。投稿共耗时4个月，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44f99168202, createdName=ms1000000537292872, createdTime=Sun Jun 02 17:13:38 CST 2024, time=2024-06-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病 经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2208736, encodeId=626e2208e36fc, content=5月20号投稿，23号with editor,到现在还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Fri Jun 07 00:51:29 CST 2024, time=2024-06-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2207788, encodeId=aef3220e7886f, content=4月中旬送外审 5月28显示外审完成 5月30显示DIP 6月1 仍旧是DIP, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210531/5f7cf98bc3ff42f9bdb3c8abf4b519fe/43510175e95b4dddbccc3b11e600cae0.jpg, createdBy=3c742286789, createdName=科研小白i, createdTime=Sat Jun 01 16:36:24 CST 2024, time=2024-06-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183371, encodeId=368621833e1d5, content=偏重的研究方向：肿瘤 经验分享：审稿人意见返回编辑那里有三周了，状态依然是Decision in Process，编辑一直不做决定，有没有人遇到过呢？可以发邮件催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=023d2396907, createdName=12346694m83(暂无昵称), createdTime=Tue Jan 23 09:38:03 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181993, encodeId=a44d21819936e, content=投稿后第四天变成了DIP，目前一周多了，发邮件给编辑也没反应，要拒也给我个准信呀。科研人时间上的无奈呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Tue Jan 16 15:58:49 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2203602, encodeId=b30c2203602ca, content=有没有已经有三个审稿人还在邀请评审专家的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Thu May 09 09:28:05 CST 2024, time=2024-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198105, encodeId=f3d8219810549, content=这个期刊不是说很快吗，投了10天，5天才到编辑那。现在在编辑那又呆了5天。着急毕业呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Fri Apr 12 09:34:50 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2200181, encodeId=320a2200181c2, content=到编辑那里第一台就Decision in Process，已经凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Wed Apr 24 19:40:05 CST 2024, time=2024-04-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2183494, encodeId=13e621834949b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：黏附分子;胃癌 经验分享：已经外审12周了，窒息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Tue Jan 23 20:06:15 CST 2024, time=2024-01-23, status=1, ipAttribution=上海)]

2024-01-23 ms9000001327347856 来自上海

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：黏附分子;胃癌
经验分享：已经外审12周了，窒息了

195 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务